INNOVADERM CRO IS NOW INDERO.

Indero Contributes to New British Journal of Dermatology Publication Exploring the Gut–Skin Connection in Chronic Hand Eczema

Author picture

What does the gut have to do with chronic hand eczema?

As it turns out, more than many might expect.

Indero is proud to share its recent contribution to a new research letter published in the British Journal of Dermatology, highlighting distinctive gut microbiome patterns observed in non‑atopic chronic hand eczema (CHE). This work adds an important layer to the emerging understanding of how systemic biological pathways, including those beyond the skin, may influence dermatological conditions.

Dr. Ana Palijan, Director of Early Phase and Translational Research at Indero, and co-author of this publication, took part in a discussion examining the science behind the study, the collaborative effort between disciplines, and the potential implications for therapeutic innovation. The conversation sheds light on how microbiome‑driven insights may help fuel the development of new approaches in dermatology research.

This publication represents a meaningful step in advancing translational research and underscores Indero’s commitment to driving scientific discovery through cross‑functional collaboration.

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.